Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8499589 | 1.00 | LMNA (0.70) | LMNABLMPTPN1MEN1CYP3A4 | |
| Squalane SCHEMBL2024387 | 1.00 | LMNA (0.70) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL18897541 | 0.87 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL20609982 | 0.87 | LMNA (0.53) | LMNABLM | |
| SCHEMBL4985635 | 0.87 | LMNA (0.53) | LMNABLMPTPN1MEN1CYP3A4 | |
| Squalane SCHEMBL4708649 | 0.84 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL2985725 | 0.84 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL29030039 | 0.84 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| Squalane SCHEMBL15449 | 0.84 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL30230194 | 0.84 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2217271-B1 | MYCOPLASMA HYOPNEUMONIAE AVIRULENT -ADJUVANTED LIVE VACCINE | ZOETIS SERVICES LLC (US) | 2016-05-04 | — | — | EP | disclosed |
| EP-1870109-B1 | COMBINED VACCINE AGAINST MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCOVIRS | ZOETIS SERVICES LLC (US) | 2016-03-16 | — | — | EP | disclosed |
| US-9238065-B2 | Mycoplasma hyopneumoniae bacterin vaccine | ZOETIS SERVICES LLC (US) | 2016-01-19 | — | — | US | disclosed |
| US-9056909-B2 | Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine | ZOETIS SERVICES LLC (US) | 2015-06-16 | — | — | US | disclosed |
| CN-104043116-A | Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine | WYETH CORP | 2014-09-17 | — | — | CN | disclosed |
| EP-1506006-B1 | IMPROVED COMBINED VACCINE AGAINST MYCOPLASMA HYOPNEUMONIAE AND PORCINE VIRUSES | ZOETIS W LLC (US) | 2013-07-31 | — | — | EP | disclosed |
| US-20120213816-A1 | MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE | WYETH LLC | 2012-08-23 | — | — | US | disclosed |
| US-8187588-B2 | Mycoplasma hyopneumoniae bacterin vaccine | WYETH LLC (US) | 2012-05-29 | — | — | US | disclosed |
| EP-2217271-A1 | MYCOPLASMA HYOPNEUMONIAE AVIRULENT -ADJUVANTED LIVE VACCINE | Wyeth LLC (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20100119471-A1 | MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE | WYETH LLC (US) | 2010-05-13 | — | — | US | disclosed |
| US-7169394-B2 | Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant | WYETH (US) | 2007-01-30 | — | — | US | disclosed |
| US-20070020296-A1 | Mycoplasma hyopneumoniae bacterin vaccine | WYETH (US) | 2007-01-25 | — | — | US | disclosed |
| US-20060228373-A1 | Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant | WYETH (US) | 2006-10-12 | — | — | US | disclosed |
| US-7018638-B2 | Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant | WYETH (US) | 2006-03-28 | — | — | US | disclosed |
| EP-1506006-A2 | IMPROVED COMBINED VACCINE AGAINST MYCOPLASMA HYOPNEUMONIAE AND PORCINE VIRUSES | Wyeth (US) | 2005-02-16 | — | — | EP | disclosed |
| WO-2004058142-A2 | IMPROVED COMBINE VACCINE AGAINST MYCOPLASMA HYOPNEUMONIAE AND PORCINE VIRUSES | WYETH (US) | 2004-07-15 | — | — | WO | disclosed |
| EP-1343525-A2 | IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE | Wyeth (US) | 2003-09-17 | — | — | EP | disclosed |
| US-20030017171-A1 | Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant | WYETH | 2003-01-23 | — | — | US | disclosed |
| US-20020131980-A1 | Mycoplasma hyopneumoniae bacterin vaccine | AMERICAN HOME PRODUCTS CORPORATIO | 2002-09-19 | — | — | US | disclosed |
| WO-2002049666-A2 | MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE | WYETH (US) | 2002-06-27 | — | — | WO | disclosed |